Edit
Serum Institute of India Pvt. Ltd.
https://www.seruminstitute.com/Last activity: 10.01.2025
Active
Serum Institute of India Pvt. Ltd. is now the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 170 countries across the globe in their national immunization programs, saving millions of lives throughout the world.
Serum Institute of India is ranked as India's No. 1 biotechnology company, manufacturing highly specialized life saving biologicals like vaccines using cutting edge genetic and cell based technologies, antisera and other medical specialties.
Serum Institute of India was founded in 1966 by Dr. Cyrus Poonawalla with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices. Thereafter, several life-saving biologicals were manufactured at prices affordable to the common man and in abundance, with the result that the country was made self-sufficient for Tetanus Anti-toxin and Anti-snake Venom serum, followed by DTP (Diphtheria, Tetanus and Pertussis) group of Vaccines and then later on MMR (Measles, Mumps and Rubella) group of vaccines.
The Philanthropic philosophy of the company still not only exists but has been proliferated to bring down the prices of newer vaccines such as Hepatitis-B vaccine, Combination vaccine etc., so that not only Indian's, but the entire under-privileged children of the world are protected from birth onwards.
Serum Institute of India is ranked as India's No. 1 biotechnology company, manufacturing highly specialized life saving biologicals like vaccines using cutting edge genetic and cell based technologies, antisera and other medical specialties.
Serum Institute of India was founded in 1966 by Dr. Cyrus Poonawalla with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices. Thereafter, several life-saving biologicals were manufactured at prices affordable to the common man and in abundance, with the result that the country was made self-sufficient for Tetanus Anti-toxin and Anti-snake Venom serum, followed by DTP (Diphtheria, Tetanus and Pertussis) group of Vaccines and then later on MMR (Measles, Mumps and Rubella) group of vaccines.
The Philanthropic philosophy of the company still not only exists but has been proliferated to bring down the prices of newer vaccines such as Hepatitis-B vaccine, Combination vaccine etc., so that not only Indian's, but the entire under-privileged children of the world are protected from birth onwards.
Location: India, Maharashtra, Pune
Employees: 1001-5000
Founded date: 1966
Mentions in press and media 40
Date | Title | Description |
10.01.2025 | Primrose Bio to Collaborate with Serum Institute of India to Develop a Novel Multi-Antigen... | - |
22.12.2024 | HERVolution Therapeutics: A New Dawn in Dark Genome Research | In the realm of biotechnology, innovation often dances in the shadows. HERVolution Therapeutics, a Copenhagen-based company, is stepping into the light with a bold mission. The company recently secured $11.7 million in Series A funding, a f... |
22.12.2024 | HERVolution Therapeutics: Dark Genome Biotech Company Raises $11.7 Million (Series A) For Advancing Treatments | HERVolution Therapeutics ApS – a dark genome-focused biotechnology company developing immunotherapies for addressing aging-related diseases – announced a $11.7 million Series A financing to advance its lead assets toward clinical evaluation... |
19.12.2024 | HERVolution Therapeutics Raises $11.7M in Series A Funding | HERVolution Therapeutics, a Copenhagen, Denmark-based dark genome-focused biotechnology company, raised $11.7M in Series A funding. The round was led by Serum Institute of India (SII) with participation from the European Innovation Council ... |
11.12.2024 | Publication of clinical Phase IIb trial data for the adjuvanted RH5.1 blood-stage malaria vaccine | Publication of clinical Phase IIb trial data for the adjuvanted RH5.1 blood-stage malaria vaccine Wed, Dec 11, 2024 12:10 CET Report this content Hørsholm, Denmark, 11 December 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Bio... |
05.11.2024 | ExpreS2ion CEO talking to BioStock about partnering efforts at BIO-Europe | ExpreS2ion CEO talking to BioStock about partnering efforts at BIO-Europe Tue, Nov 05, 2024 08:15 CET Report this content Heading towards phase I studies with breast cancer vaccine candidate ES2B-C001, ExpreS2ion Biotech is actively looking... |
21.10.2024 | Adar Poonawalla invests Rs 1,000 Cr in Dharma Productions for a 50% stake Recommended Stories For You | Adar Poonawalla-led Serene Productions on Monday said it invested Rs 1,000 crore in Karan Johar’s Dharma Productions and its digital content arm, Dharmatic Entertainment. This strategic investment will give Serene Productions a 50% ownershi... |
17.10.2024 | Burkert inaugurates manufacturing facility in Pune, aims to strengthen portfolio in India | Burkert Fluid Control Systems India Private Limited, a prominent manufacturer of measurement and control systems for liquids and gases, has inaugurated its new manufacturing facility in Pune, Maharashtra, with a grand ceremony. This state-o... |
16.10.2024 | ExpreS2ion and Serum Institute of India have entered in a term sheet regarding proposed development and commercialisation of novel malaria vaccines | ExpreS2ion and Serum Institute of India have entered in a term sheet regarding proposed development and commercialisation of novel malaria vaccines Wed, Oct 16, 2024 13:17 CET Report this content Hørsholm, Denmark, 16 October 2024 – ExpreS2... |
17.08.2024 | Chipmaker Texas Instruments to receive up to $1.6 billion in funding from US | ETtech Texas Instruments said on Friday it would receive up to $1.6 billion in funding from the U.S. Commerce Department towards the construction of three new facilities, the latest government outlay aimed at bolstering domestic chip produc... |
Show more